COMMUNIQUÉS West-GlobeNewswire

Hospital shooting highlights the dangers and violence nurses often face at work
23/02/2025
One in four nurses face workplace violence, a rate higher than police and correctional officers. SILVER SPRING, MD, Feb. 22, 2025 (GLOBE NEWSWIRE) -- SILVER SPRING, MD – The American Nurses Association (the association [...]
Bay Area Cognitive Behavioral Therapy Center Expands Treatment Offerings with Acceptance and Commitment Therapy
22/02/2025
Bay Area Therapy Center Expand Treatment Options Offering Comprehensive Mental Health Services in San Francisco SAN FRANCISCO, Feb. 22, 2025 (GLOBE NEWSWIRE) -- The Bay Area Cognitive Behavioral Therapy Center , a [...]
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
22/02/2025
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre- [...]
Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn
22/02/2025
ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn De nouvelles données détaillées de l’ [...]
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
22/02/2025
Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ET New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
21/02/2025
SAN CARLOS, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21/02/2025
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
21/02/2025
Monrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, [...]
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
21/02/2025
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the [...]
Fortrea to Add Erin L. Russell to Board of Directors
21/02/2025
Fortrea and Starboard enter into Cooperation Agreement DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint [...]
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
21/02/2025
600% higher market cap per team member when compared to industry average. Source: Mr. Damodaran at the Stern School of Business at NYU . Current ownership breakdown: Insiders 79%; Independent Board Members 1%; Lead [...]
Dogecoin Cash, Inc. (OTC:CBDS) Announces Strategic Expansion of Crypto Holdings with Acquisition of 420 Million Dogecoin Cash ($DOG)
21/02/2025
Update on Preferred Dividend Mesquite, Feb. 21, 2025 (GLOBE NEWSWIRE) -- February 21, 2025 – Mesquite, NV – Dogecoin Cash, Inc., formerly, Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce the execution of a [...]
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
21/02/2025
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, manufacturing, [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025
21/02/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
21/02/2025
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]
Singular Genomics Announces Closing of Acquisition by Deerfield Management
21/02/2025
SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
Ipsen S.A. publishes its 2024 consolidated financial statements
21/02/2025
Ipsen S.A. - 2024 Consolidated Financial Statements Attachment Ipsen_Consolidated financial statements 2024_EN
Ipsen S.A. publie ses comptes consolidés 2024
21/02/2025
Ipsen S.A. - Etats financiers consolidés 2024 Pièce jointe Ipsen_Comptes Consolidés 2024_FR
Correction: Aino Health year-end report January-December 2024
21/02/2025
Correction: The reason for the correction is that the previous mailing did not contain the attached report. This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish [...]

Pages